title: Outcomes of autologous hematopoietic cell transplantation in primary amyloidosis after bortezomib-based induction therapy.
authors.affiliation: Department of Internal Medicine, Cleveland Clinic, Cleveland, OH, USA.
authors.forename: S
authors.initials: S
authors.lastname: Hong
authors.affiliation: Department of Hematology and Oncology, Cleveland Clinic, Cleveland, OH, USA.
authors.forename: J
authors.initials: J
authors.lastname: Valent
authors.affiliation: Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA.
authors.forename: L
authors.initials: L
authors.lastname: Rybicki
authors.affiliation: Blood & Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
authors.forename: D
authors.initials: D
authors.lastname: Abounader
authors.affiliation: Department of Hematology and Oncology, Cleveland Clinic, Cleveland, OH, USA.|Blood & Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
authors.forename: B
authors.initials: B
authors.lastname: Bolwell
authors.affiliation: Department of Hematology and Oncology, Cleveland Clinic, Cleveland, OH, USA.|Blood & Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
authors.forename: R
authors.initials: R
authors.lastname: Dean
authors.affiliation: Department of Hematology and Oncology, Cleveland Clinic, Cleveland, OH, USA.|Blood & Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
authors.forename: A T
authors.initials: AT
authors.lastname: Gerds
authors.affiliation: Department of Hematology and Oncology, Cleveland Clinic, Cleveland, OH, USA.|Blood & Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
authors.forename: D
authors.initials: D
authors.lastname: Jagadeesh
authors.affiliation: Department of Hematology and Oncology, Cleveland Clinic, Cleveland, OH, USA.|Blood & Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
authors.forename: B K
authors.initials: BK
authors.lastname: Hamilton
authors.affiliation: Department of Hematology and Oncology, Cleveland Clinic, Cleveland, OH, USA.|Blood & Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
authors.forename: B
authors.initials: B
authors.lastname: Hill
authors.affiliation: Department of Hematology and Oncology, Cleveland Clinic, Cleveland, OH, USA.|Blood & Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
authors.forename: M E
authors.initials: ME
authors.lastname: Kalaycio
authors.affiliation: Department of Hematology and Oncology, Cleveland Clinic, Cleveland, OH, USA.|Blood & Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
authors.forename: B
authors.initials: B
authors.lastname: Pohlman
authors.affiliation: Department of Hematology and Oncology, Cleveland Clinic, Cleveland, OH, USA.|Blood & Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
authors.forename: F
authors.initials: F
authors.lastname: Reu
authors.affiliation: Department of Hematology and Oncology, Cleveland Clinic, Cleveland, OH, USA.|Blood & Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
authors.forename: C
authors.initials: C
authors.lastname: Samaras
authors.affiliation: Department of Hematology and Oncology, Cleveland Clinic, Cleveland, OH, USA.|Blood & Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
authors.forename: R
authors.initials: R
authors.lastname: Sobecks
authors.affiliation: Department of Hematology and Oncology, Cleveland Clinic, Cleveland, OH, USA.|Blood & Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
authors.forename: N S
authors.initials: NS
authors.lastname: Majhail
authors.affiliation: Department of Hematology and Oncology, Cleveland Clinic, Cleveland, OH, USA.|Blood & Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
authors.forename: H D
authors.initials: HD
authors.lastname: Liu
mesh_terms: D000328:Adult; D000368:Aged; D000069286:Bortezomib / Q000627:therapeutic use*; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D000075363:Immunoglobulin Light-chain Amyloidosis / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011719:Pyrazines / Q000627:therapeutic use; D012189:Retrospective Studies; D014182:Transplantation, Autologous
chemical_list: D011719:Pyrazines; D000069286:Bortezomib